Amneal Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Amneal Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AMRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001723128
Board of directors
-
Chintu Patel · Director · Co-CEOSince 2023
-
Chirag K. Patel · Director · President & Co-CEOSince 2023
-
Deborah M. Autor · DirectorSince 2023
-
Emily Peterson Alva · DirectorSince 2023
-
Gautam Patel · DirectorSince 2023
-
J. Kevin Buchi · DirectorSince 2023
-
Jeffrey P. George · DirectorSince 2023
-
John Kiely · DirectorSince 2023
- Since 2023
-
Shlomo Yanai · DirectorSince 2023
-
Ted C. Nark · DirectorSince 2023
Chief executives
Chirag K. Patel
· President & Co-CEO
Dates unknown
Chintu Patel
· Co-CEO
Dates unknown
Board connections
7 of this board's directors also sit on 11 other boards.
- via Jeffrey P. George
- via Emily Peterson Alva
- via Paul M. Meister
- via J. Kevin Buchi
- via Deborah M. Autor
- via Jeffrey P. George
- via Paul M. Meister
- via Shlomo Yanai
- via Paul M. Meister
- via Gautam Patel
- via Paul M. Meister
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $9,824,848
- 7 sales by 5 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | J. Kevin Buchi Director | Gift | −20,445 | — | — |
| Sep 11, 2026 | J. Kevin Buchi Director | Option exercise | +20,445 | $14.45 | $295,430 |
| Sep 1, 2026 | BOYER ANDREW S Officer (Executive Vice President) | Gift | −80,000 | — | — |
| Aug 21, 2026 | BOYER ANDREW S Officer (Executive Vice President) | Gift | −152,426 | — | — |
| Aug 13, 2026 | John Kiely Director | Open-market sale | −50,000 | $17.64 | $882,000 |
| Aug 13, 2026 | John Kiely Director | Gift | −10,000 | — | — |
| Aug 12, 2026 | Shah Nikita Officer (Executive Vice President) | Open-market sale | −146,403 | $17.51 | $2,563,517 |
| Aug 12, 2026 | Daly Jason B. Officer (EVP, Chief Legal Officer) | Open-market sale | −210,000 | $17.40 | $3,654,000 |
| Aug 11, 2026 | J. Kevin Buchi Director | Option exercise | −168,573 | $17.18 | $2,896,084 |
| Aug 11, 2026 | Daly Jason B. Officer (EVP, Chief Legal Officer) | Open-market sale | −6,613 | $17.70 | $117,050 |
| Aug 10, 2026 | Patel Tushar Bhikhubhai 10% owner | Grant or award | +12,763,469 | — | — |
| Aug 10, 2026 | Chirag K. Patel Director, Officer (President & Co-CEO) | Grant or award | +6,381,734 | — | — |
| Aug 10, 2026 | Gautam Patel Director | Grant or award | +283,632 | — | — |
| Aug 10, 2026 | Chintu Patel Director, Officer (Co-CEO) | Grant or award | +6,381,734 | — | — |
| May 11, 2026 | Deborah M. Autor Director | Open-market sale | −34,819 | $12.94 | $450,558 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.